John K. Cini's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 12,000 Common Stock done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Hol... | John K. Cini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 12,000 | 14,116 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | K. Cini John | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 1,888 | 2,116 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | John K. Cini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2023 | 18,551 | 40,271 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | John K. Cini | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2023 | 18,551 | 21,720 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | John K. Cini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 18,551 | 322,652 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | John K. Cini | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.51 per share. | 25 May 2021 | 14,004 | 224,067 | - | 1.5 | 21,146 | Common Stock |